Korean J Med.
1999 Feb;56(2):189-195.
Clinical Manifestation of 16 cases with Insulinoma or Nesidioblastosis
- Affiliations
-
- 1Department of Internal Medicine, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.
- 2Department of General Surgery, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.
- 3Department of Diagnostic Radiology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.
Abstract
-
Insulinoma is the most important cause of hyperinsulinemic hypoglycemia. Insulinoma can be
cured by surgical management but diagnosis and localization are difficult due to their small
size and variable clinical manifestation. We studied clinical manifestation of the patients who
were diagnosed as insulinoma or nesidioblastosis.
METHODS
We studied clinical charts of 16 patients who underwent operation under the impression
of insulinoma from 1990 to 1997.
RESULTS
1) Of the 16 patients, 13 had insulinoma and 3 had nesidioblastosis. 2) Neuroglycopenic
symptoms were present in all cases. Among them, loss of consciousness or confusion were present
in 12 cases (75%). Adrenergic symptoms were present in 9 cases (56%). Mean symptom duration
until diagnosis was 39 months(range; 15days~10years). 3) 72 hr fasting test showed hypoglycemia
in all cases. 4) Insulin/glucose ratio was above 0.3 except for two cases. 5) CT and MRI had low
sensitivity (38%) and specificity (33%) as a preoperative tumor localization tool, and more
invasive technique, i.e., selective angiography and transhepatic portal vein sampling, were
necessary in most cases.
CONCLUSION
Nsidioblastosis may be more prevalent than previously suspected. Diagnosis of
insulinoma is not always easy and invasive diagnostic methods should be considered when the
clinical suspicion is high, even if biochemical and noninvasive localization tools give
negative results.